DAA-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment

Details for Australian Patent Application No. 2009278279 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Lehmann, Lutz; Thiele, Andrea; Heinrich, Tobias; Vollmer, Sonja

Agent Davies Collison Cave

Pub. Number AU-A-2009278279

PCT Pub. Number WO2010/015387

Priority 08161903.3 06.08.08 EP

Filing date 5 August 2009

Wipo publication date 11 February 2010

International Classifications

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

C07B 59/00 (2006.01) Introduction of isotopes of elements into organic compounds

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/015387 Priority application(s): WO2010/015387

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009278283-Surface portion

2009278275-Method for producing microlenses